P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION

• Ivetta Danylesko,
• Noga Shem-Tov,
• Ronit Yerushalmi,
• Elad Jacoby,
• Amos Toren,
• Orit Itzhaki,
• Roni Shouval,
• Avichai Shimoni,
• Avigdor Abraham,
• Arnon Nagler

Affiliations

Ivetta Danylesko

1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel

Noga Shem-Tov

1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel

Ronit Yerushalmi

1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel

Elad Jacoby

2 Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv-Yafo, Israel

Amos Toren

2 Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv-Yafo, Israel

Orit Itzhaki

2 Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv-Yafo, Israel

Roni Shouval

1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel

Avichai Shimoni

1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel

Avigdor Abraham

1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel

Arnon Nagler

1 Sheba Medical Center, Division of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel